If you’re looking for a Lyme disease vaccine, you can choose from among several—for your dog. A vaccine for humans hasn’t been available for years and few companies have tried to fill that void. Valneva has advanced its Lyme vaccine candidate to mid-stage clinical testing, and the company now has the help of drug giant Pfizer to continue its development.
The companies announced on Thursday an agreement to take the Valneva vaccine candidate, VLA15, through late-stage clinical testing, and, if approved, commercialization. Pfizer (NYSE: PFE) is paying Saint Herblain, France-based Valneva $130 million up front to start the partnership.
Lyme… Read more »
UNDERWRITERS AND PARTNERS
